Summit Therapeutics (SMMT) null Earnings

11MayConfirmed
Q2 2021
Nov 21
Mar 22
May 22
-1
-0.74
-0.48
-0.22

Details

Expected EPS
-0.28
Actual EPS
-0.22
Surprise EPS
0.06
Surprise Percent
+21.43%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.22 per share for .

0 Comments

Share your thoughts